☆ 4.5 Letter

Re: Stefano Fanti, Alberto Briganti, Louise Emmett, et al. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy. Eur Urol Oncol. 2022;5:530-6 Extended Use of PSMA PET/CT in Candidates for Focal Therapy

EUROPEAN UROLOGY ONCOLOGY (2022)

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study

Andrei Gafita et al.

Summary: The objective of this study was to develop a novel framework for response evaluation in prostate-specific membrane antigen PET/CT and determine its prognostic value for overall survival. The results showed that RECIP 1.0 had predictive value for OS and PSA 1 RECIP had higher predictive accuracy compared to PSA responses.

JOURNAL OF NUCLEAR MEDICINE (2022)

添加到收藏夹

Article Oncology

EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy

Stefano Fanti et al.

Summary: The use and potential of PSMA PET/CT in prostate cancer treatment and management were assessed and achieved consensus among a panel of experts, particularly in utilizing PSMA PET/CT for patient selection and guiding [177Lu]Lu-PSMA therapy.

EUROPEAN UROLOGY ONCOLOGY (2022)

添加到收藏夹

Editorial Material Urology & Nephrology

The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study

Louise Emmett et al.

Summary: The combination of PSMA + MRI shows higher negative predictive value and sensitivity for detecting clinically significant prostate cancer compared to MRI alone, but with a lower specificity. Combined PSMA + MRI may help avoid unnecessary prostate biopsies in some men.

EUROPEAN UROLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

Prospective Evaluation of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer Diagnosis

Egesta Lopci et al.

Summary: The study aimed to test the diagnostic performance of Ga-68-PSMA PET/CT in detecting clinically significant prostate cancer in patients with a high suspicion of cancer. Ga-68-PSMA PET/CT proved capable of accurately detecting prostate cancer and identifying clinically relevant PCa.

EUROPEAN UROLOGY FOCUS (2021)

添加到收藏夹

Article Medicine, General & Internal